KITE & Gilead UK/I 2023 CAR-T Fellowship and Medical Grants Programme now open

Subject heading: KITE & Gilead UK/I 2023 CAR-T Fellowship and Medical Grants Programme now open

Do you have a project that could improve patient care in the field of CAR T-cell therapy and haemato-oncology?

The Kite and Gilead UK & Ireland Fellowship and Medical Grants Programme (GFP) is a medical grants funding stream that helps drive innovation and supports best practice sharing initiatives amongst healthcare professionals. Its aim is to help improve patient care within the field of CAR T-cell therapy and haemato-oncology. The GFP has funded nearly 350 projects since 2008.

The 2023 CAR-T GFP is accepting applications until June 30th.

The GFP accepts applications for projects that will add clinical value or address an unmet need in the care of patients within the field of CAR T-cell therapy and haemato-oncology. If you have a project that falls outside of this scope, but which will add clinical value or which investigates an area of unmet need within CAR T-cell therapy and haemato-oncology, you may still apply.

If you are interested in learning about the GFP or the application process, or to check if your project is eligible for a grant and apply, please visit the Gilead UK and Ireland website here. For general enquiries or questions about an application, please email [email protected] for support.

Disclaimer: The Kite and Gilead UK & Ireland Fellowship and Medical Grants Programme is fully operated and funded by Kite, a Gilead Company.

 

 

Date of preparation: April 2023

Code: UK-UNB-3782

Latest News

By BOPA Executive Committee on 4th November 2025

Joint BOPA and PASG Position Statement Safer Handling of Hazardous SACT Drugs: A Pharmacy Workforce Position Statement

BOPA and PASG Publish Joint Position Statement on the Safer Handling of Hazardous SACT Drugs The British Oncology Pharmacy Association (BOPA) and the NHS Pharmaceutical Aseptic Services Group (PASG) have…

Read article
By Jennifer Allen - LCC Lead on 4th November 2025

BOPA’s Let’s Communicate Cancer (LCC) series receives re-accreditation from the Royal Society for Public Health (RSPH)

The Let’s Communicate Cancer (LCC) series, available for free on the BOPA website CancerHUB: Home Page – BOPA, has recently received re-accreditation from the Royal Society for Public Health which…

Read article
By BOPA Executive Committee on 3rd November 2025

BOPA’s Submission for the National Cancer Plan for England 2025 – Call for Evidence

With the National Cancer Plan 2025 for England Publication imminent (Shaping the national cancer plan – GOV.UK) – please find BOPA’s Submission for the call for evidence below: BOPA Submission…

Read article
By BOPA IOSIG on 1st November 2025

IOCN UK-wide Survey: Access to Immunosuppressants for ICI Adverse Events

  IOCN UK-wide Survey: Access to Immunosuppressants for ICI Adverse Events Have your say on a critical issue affecting immunotherapy patients across the UK. The IOCN and UKSACT Board have…

Read article